Afatinib Tablet, Film Coated
Product Images NDC 31722-783

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Afatinib (NDC 31722-783). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Afatinib20mgcarton (Afatinib20mgcarton)

Packaging label for Afatinib Tablets 20 mg by Camber Pharmaceuticals, Inc. The label shows a 30-tablet count of film-coated oral tablets. The label includes storage instructions, dosage strength, manufacturer and labeler information, and barcodes on the carton. It also notes the tablets contain 20 mg afatinib per tablet.*

FDA Label Image

Afatinib20mglabel (Afatinib20mglabel)

Afatinib Tablets 20 mg film-coated oral tablets manufactured for Camber Pharmaceuticals, Inc. The label indicates a 30 tablet count, includes dosage storage instructions, and features barcodes and manufacturing details by Hetero Labs Limited in India.*

FDA Label Image

Afatinib30mgcarton (Afatinib30mgcarton)

Packaging label for Afatinib Tablets 30 mg film-coated tablets by Camber Pharmaceuticals, Inc. The label shows the product name, strength, NDC 31722-782-30, quantity of 30 tablets, and manufacturer details including Hetero Labs Limited in India. Storage instructions and dosage information are provided, along with barcodes and contact information for the U.S.*

FDA Label Image

Afatinib30mglabel (Afatinib30mglabel)

Afatinib Tablets 30 mg film-coated oral tablets packaging label. The label shows the product name, strength, and quantity of 30 tablets. It is manufactured for Camber Pharmaceuticals, Inc., with manufacturing by Hetero Labs Limited, India. Storage instructions and U.S. contact number are also visible, along with the NDC 31722-782-30.*

FDA Label Image

Afatinib40mgcarton (Afatinib40mgcarton)

Packaging label for Afatinib Tablets 40 mg film-coated tablets by Camber Pharmaceuticals, Inc. The label indicates a quantity of 30 tablets for oral use. It includes storage instructions to keep the medication protected from light and humidity, and provides a U.S. contact number. The label also identifies the manufacturer as Hetero Labs Limited, India, and shows the NDC 31722-783-30.*

FDA Label Image

Afatinib40mglabel (Afatinib40mglabel)

Afatinib Tablets 40 mg film-coated tablets label from Camber Pharmaceuticals, Inc. The label indicates dispensing instructions, recommended storage conditions, and dosage information. It also includes the NDC number 31722-783-30 and the package size of 30 tablets. The label shows manufacturing details and a barcode on a white background with blue and black text.*

FDA Label Image

Afatinibcamberlogo (Afatinibcamberlogo)

FDA Label Image

Afatinibfig1 (Afatinibfig1)

A Kaplan-Meier survival curve graph showing estimated progression-free survival (PFS) probability over time in months for Afatinib 40 mg compared to Pe500+Cis75 treatment groups. The graph includes survival probabilities, median PFS times, hazard ratio with 95% confidence intervals, log-rank test p-value, and number at risk for each group at various time points up to 27 months.*

FDA Label Image

Afatinibfig2 (Afatinibfig2)

A chart showing two forest plots comparing Afatinib and Pem/Cis by EGFR mutation category. The plots display hazard ratios (HR) and median progression-free survival (PFS) and overall survival (OS) in months for Del 19/L858R, Del 19, and L858R mutation categories. The x-axis is logarithmic, indicating favorability toward Afatinib or Pem/Cis.*

FDA Label Image

Afatinibfig3 (Afatinibfig3)

A Kaplan-Meier survival curve chart comparing estimated overall survival (OS) probability over time in months for two drugs: Afatinib and Erlotinib. The x-axis shows time of overall survival in months, and the y-axis shows estimated OS probability from 0 to 1. The chart includes the number of subjects at risk at various time points for each drug.*

FDA Label Image

Afatinibstructure (Afatinibstructure)

Chemical structure of Afatinib, a human prescription drug. The diagram shows the molecular formula including multiple ring structures and side groups with elements such as chlorine, fluorine, nitrogen, and oxygen.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.